Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma

Yingdan Wanga Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Yunping Maa Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Yan Xub The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, People’s Republic of China;c Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People’s Hospital Affiliated with Jinan University, Jinan University, Zhuhai, People’s Republic of ChinaView further author information

Jiangyan Liua Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Xiang Lia Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Yuyuan Chenb The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, People’s Republic of China;c Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People’s Hospital Affiliated with Jinan University, Jinan University, Zhuhai, People’s Republic of ChinaView further author information

Yan Chenb The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, People’s Republic of China;c Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People’s Hospital Affiliated with Jinan University, Jinan University, Zhuhai, People’s Republic of ChinaView further author information

Jun Xied Department of Joint Orthopedics, Guanghua Hospital Affiliated to Shanghai, University of Traditional Chinese Medicine, Shanghai, People’s Republic of ChinaView further author information

Lianbo Xiaod Department of Joint Orthopedics, Guanghua Hospital Affiliated to Shanghai, University of Traditional Chinese Medicine, Shanghai, People’s Republic of ChinaView further author information

Zheng Xiange Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Fan Wua Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Jinghe Huanga Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information

show all

Click to increase image sizeClick to decrease image size

Acknowledgements

We gratefully acknowledge the originating and submitting laboratories who contributed sequences to GISAID. This work was supported by the National Natural Science Foundation of China (31771008 to JH), the National Major Science and Technology Projects of China (2017ZX10202102 to JH and 2018ZX10301403 to FW), the Hundred Talent Program of Shanghai Municipal Health Commission (2018BR08 to JH), the Chinese Academy of Medical Sciences (2019PT350002 to JH).

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by the National Natural Science Foundation of China [grant number 31771008 to JH], National Science and Technology Major Project of the Ministry of Science and Technology of China [grant number 2017ZX10202102 to JH], [grant number 2018ZX10301403 to FW], Shanghai Municipal Health Commission of Health and Family Planning Foundation [grant number 2018BR08 to JH], the Chinese Academy of Medical Sciences [grant number 2019PT350002 to JH].

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma

Information for

Open access

Opportunities

Help and information

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma

Acknowledgements

Disclosure statement

Additional information

Funding

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature